Lung Cancer | Specialty

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Dr. Thawani on AEs With Radiation Versus COVID-19 Symptoms in Lung Cancer

May 23rd 2020

Nitika Thawani, MD, discusses identifying the difference between adverse events that are associated with radiation versus COVID-19 symptoms in lung cancer.

Dr. Dimou on Managing Disease Progression in NSCLC

May 22nd 2020

Anastasios (Tassos) Dimou, MD, shares advice from managing patients with non–small cell lung cancer who experience disease progression following therapy.

Future of NTRK Fusions

May 21st 2020

Challenges for TRK Fusion–Targeting Agents

May 21st 2020

Acquired Resistance in TRK Fusion-Positive Cancers

May 21st 2020

Approaching Treatment for TRK Fusion–Positive Cancers

May 21st 2020

TRK Inhibitor in GI Cancers: Adverse Effect Profile

May 21st 2020

Efficacy of TRK Inhibitors

May 21st 2020

Early Development of TRK Inhibitors

May 21st 2020

Advice for Interpreting NGS Reports

May 21st 2020

Driver Mutations in NTRK Fusion-Positive Cancers

May 21st 2020

Genomic Testing for NTRK Fusions in Lung and GI Cancers

May 21st 2020

Approaching Genomic Testing for NTRK Fusions

May 21st 2020

Using Molecular Testing in GI Cancers

May 21st 2020

Evolution of NGS Testing in Lung Cancers

May 21st 2020

Variants of NTRK Fusions in Solid Tumors

May 21st 2020

Role of NTRK Inhibitors

May 21st 2020

ASCO 2020: Top KOLs Select Vital Studies Ahead of Virtual Meeting

May 21st 2020

Ahead of the 2020 ASCO Virtual Scientific Program, we spoke with a handful of leading oncologists in breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, and hematologic malignancies to gain their perspectives on the most significant studies in their respective specialties.

Dr. Bazhenova on the PACIFIC Trial With Durvalumab in NSCLC

May 20th 2020

Lyudmila A. Bazhenova, MD, discusses the PACIFIC study with durvalumab in stage III non–small-cell lung cancer.

Dr. Carbone on the Impact of Immunotherapy in Lung Cancer

May 19th 2020

David P. Carbone, MD, PhD, discusses the impact of immunotherapy on lung cancer.